Lipella Pharmaceuticals Inc.
LIPO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $3,197 | $6,119 | $12,704 | $2,682 |
| - Cash | $2,185 | $3,294 | $5,122 | $1,414 |
| + Debt | $48 | $137 | $430 | $283 |
| Enterprise Value | $1,060 | $2,961 | $8,012 | $1,551 |
| Revenue | $536 | $450 | $184 | $259 |
| % Growth | 19.3% | 144.2% | -29% | – |
| Gross Profit | -$3,077 | -$2,589 | -$2,364 | -$1,197 |
| % Margin | -573.7% | -575.9% | -1,283.4% | -461.7% |
| EBITDA | -$5,013 | -$4,606 | -$2,588 | -$1,859 |
| % Margin | -934.7% | -1,024.5% | -1,405.4% | -716.7% |
| Net Income | -$5,016 | -$4,619 | -$2,598 | -$1,865 |
| % Margin | -935.2% | -1,027.3% | -1,410.6% | -719.3% |
| EPS Diluted | -4.79 | -6.16 | -5.12 | -4.38 |
| % Growth | 22.2% | -20.3% | -16.9% | – |
| Operating Cash Flow | -$3,951 | -$3,150 | -$1,831 | -$989 |
| Capital Expenditures | -$0 | -$14 | $0 | $0 |
| Free Cash Flow | -$3,951 | -$3,165 | -$1,831 | -$989 |